Michael Weinfeld

Affiliations: 
Experimental Oncology University of Alberta, Edmonton, Alberta, Canada 
Area:
Molecular Biology, Oncology
Google:
"Michael Weinfeld"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rashed FB, Kate WD, Fanta M, et al. (2023) Influence of 2-Nitroimidazoles in the Response of FaDu Cells to Ionizing Radiation and Hypoxia/Reoxygenation Stress. Antioxidants (Basel, Switzerland). 12
Jackson N, Alhussan A, Bromma K, et al. (2022) Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation Response. Pharmaceutics. 14
Turchi JJ, Pawelczak KS, Weinfeld M, et al. (2022) Editorial: Targeting DNA repair and the DNA damage response: Beyond the standard PI3 kinase-like kinases. Frontiers in Oncology. 12: 1023500
Rashed FB, Diaz-Dussan D, Mashayekhi F, et al. (2022) Cellular mechanism of action of 2-nitroimidazoles as hypoxia-selective therapeutic agents. Redox Biology. 52: 102300
Rychlowska M, Agyapong A, Weinfeld M, et al. (2022) Zika Virus Induces Mitotic Catastrophe in Human Neural Progenitors by Triggering Unscheduled Mitotic Entry in the Presence of DNA Damage While Functionally Depleting Nuclear PNKP. Journal of Virology. e0033322
Weilbeer C, Jay D, Donnelly JC, et al. (2022) Modulation of ERCC1-XPF Heterodimerization Inhibition Structural Modification of Small Molecule Inhibitor Side-Chains. Frontiers in Oncology. 12: 819172
Jiang B, Murray C, Cole BL, et al. (2022) Mutations of the DNA repair gene PNKP in a patient with microcephaly, seizures, and developmental delay (MCSZ) presenting with a high-grade brain tumor. Scientific Reports. 12: 5386
Shin W, Alpaugh W, Hallihan LJ, et al. (2021) PNKP is required for maintaining the integrity of progenitor cell populations in adult mice. Life Science Alliance. 4
Ciniero G, Elmenoufy AH, Gentile F, et al. (2021) Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1-XPF-mediated DNA repair. Cancer Chemotherapy and Pharmacology
Elmenoufy AH, Gentile F, Jay D, et al. (2020) Design, synthesis and in vitro cell-free/cell-based biological evaluations of novel ERCC1-XPF inhibitors targeting DNA repair pathway. European Journal of Medicinal Chemistry. 204: 112658
See more...